Publications
Study design: Randomized double blind, placebo-controlled trial. Objectives: To examine the effect of early intravenous zoledronic acid (ZA) on bone markers and areal bone mineral density (aBMD) in persons with acute ASIA Impairment Scale (AIS) A traumatic spinal cord injury (SCI). Setting: Two inpatient rehabilitation units. Methods: Thirteen men, ...